Navigation Links
Pfizer supports open access publishing for researchers in low-income countries
Date:5/5/2009

Today, Pfizer announced an agreement with BioMed Central to launch an open access waiver fund which will support automatic waivers of publication fees for authors from low-income countries.

Thanks to the open access waiver fund, researchers in low-income countries can publish research articles in BioMed Central's open access journals without the need to pay a publication fee.

Speaking of the agreement Dr Jack Watters, Vice President, Pfizer External Medical Affairs said "Pfizer's support for open access publishing is driven by a recognition of the wide benefits of global access to the latest research results, and the crucial role that open access journals can play in the communication of those results. In addition, we feel that it is critically important that the benefits of scientific publication are extended to all scientists who do quality research, and that providing this access will promote much-needed recognition of research conducted in developing countries.

Matthew Cockerill, BioMed Central's Managing Director, commented: "Researchers working in low-income countries have been strong supporters of open access publishing. Many of BioMed Central's most successful journals such as Malaria Journal and BMC Public Health, focus on issues of strong relevance to developing countries and publish many articles from these countries. BioMed Central's policy of automatic waivers for low-income countries ensures that researchers based in these countries will face no financial barrier to publishing and sharing their work in a way that makes it globally accessible."


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-020-319-22216
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. Pfizer inks global license to Genomatix Software and databases
2. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
3. $10 million Simons Foundation gift supports new initiative with Institute for Advanced Study
4. Lancet study supports new, highly effective treatment for blood disorder
5. Research supports toxoplasmosis link to schizophrenia
6. VCU survey: US public supports genetic research, testing and government spending on research
7. Synthetic virus supports a bat origin for SARS
8. The MDS foundation supports vidazas recommendation for European approval
9. The MDS Foundation supports the FDAs decision to expand vidaza label to include survival data
10. New book further supports controversial theory of Man the Hunted
11. Grant supports emerging field of massive data analysis and visual analytics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
Breaking Biology News(10 mins):
(Date:6/14/2017)... ... June 14, 2017 , ... Delpor, Inc. ( Delpor ), a biotechnology company ... from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the ... The product is based on Delpor’s NANOPOR™ technology and is expected to ...
(Date:6/13/2017)... ... June 13, 2017 , ... ... has chosen The Copley Consulting Group to facilitate and deploy Infor’s CloudSuite ... its manufacturing operations and strategic initiatives to increasing customer demands. , “The ...
(Date:6/13/2017)... ... June 13, 2017 , ... ... deep learning research, today announced that it will offer the new NVIDIA® DGX ... on the NVIDIA Volta™ architecture. , “NVIDIA’s DGX portfolio is paving the way ...
(Date:6/13/2017)... ... June 13, 2017 , ... Presented at American Diabetes Association: Abstract #2017-LB-7091-Diabetes, ... went on to develop chronic kidney disease within four years , Study ... evaluated 792 patients over a four year period , Results presented at ...
Breaking Biology Technology: